UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease

Frontiers in pharmacology, 2021-04, Vol.12, p.650597-650597

2021

Volltextzugriff (PDF)

The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene

Frontiers in synaptic neuroscience, 2021-04, Vol.13, p.638519

2021

Volltextzugriff (PDF)

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

Movement disorders, 2019-02, Vol.34 (2), p.180-198

2019

Volltextzugriff (PDF)

New treatments for levodopa-induced motor complications

Movement disorders, 2015-09, Vol.30 (11), p.1451-1460

2015

Volltextzugriff (PDF)

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

Movement disorders, 2011-10, Vol.26 (S3), p.S42-S80

2011

Volltextzugriff (PDF)

Sleep habits, alertness, cortisol levels, and cardiac autonomic activity in short-distance bus drivers: differences between morning and afternoon shifts

Journal of occupational and environmental medicine, 2011-07, Vol.53 (7), p.806-811

2011

Volltextzugriff (PDF)

Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database

Parkinsonism & related disorders, 2021-05, Vol.86, p.34-37

2021

Volltextzugriff (PDF)

State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease

Expert opinion on pharmacotherapy, 2020-03, Vol.21 (4), p.445-457

2020

Volltextzugriff (PDF)

Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations

Movement disorders, 2021-02, Vol.36 (2), p.283-297

2021

Volltextzugriff (PDF)

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases

Expert opinion on pharmacotherapy, 2019-04, Vol.20 (6), p.635-645

2019

Volltextzugriff (PDF)

Diagnosis and Management of Pain in Parkinson's Disease: A New Approach

Drugs & aging, 2021-07, Vol.38 (7), p.559-577

2021

Volltextzugriff (PDF)

Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease

Clinical autonomic research, 2020-06, Vol.30 (3), p.265-271

2020

Volltextzugriff (PDF)

Heart Rate Nonlinear Dynamics During Sudden Hypoxia at 8230 m Simulated Altitude

Wilderness & environmental medicine, 2010-03, Vol.21 (1), p.4-10

2010

Volltextzugriff (PDF)

Gender-related differences in urinary 6-sulfatoxymelatonin levels in obese pubertal individuals

Journal of pineal research, 2006-04, Vol.40 (3), p.214-218

2006

Volltextzugriff (PDF)

Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO Trial

Movement disorders, 2021-07, Vol.36 (7), p.1704-1711

2021

Volltextzugriff (PDF)

Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France

Movement disorders, 2011-10, Vol.26 (12), p.2226-2231

2011

Volltextzugriff (PDF)

Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life

Scientific reports, 2021-05, Vol.11 (1), p.9611-9611, Article 9611

2021

Volltextzugriff (PDF)

Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia

Journal of Neural Transmission, 2018-08, Vol.125 (8), p.1237-1250

2018

Volltextzugriff (PDF)

Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort

Parkinsonism & related disorders, 2015-11, Vol.21 (11), p.1323-1329

2015

Volltextzugriff (PDF)

Cardiac autonomic activity predicts dominance in verbal over spatial reasoning tasks: Results from a preliminary study

Autonomic neuroscience, 2012-04, Vol.167 (1), p.78-80

2012

Volltextzugriff (PDF)

What Is In A Name?

Movement disorders, 2024-09, Vol.39 (9), p.1651-1652

2024

Volltextzugriff (PDF)

Test–retest reliability of the Friedreich’s ataxia rating scale

Annals of clinical and translational neurology, 2020-09, Vol.7 (9), p.1708-1712

2020

Volltextzugriff (PDF)

Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson’s Disease

CNS drugs, 2010-11, Vol.24 (11), p.941-968

2010

Volltextzugriff (PDF)

Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review

Movement disorders clinical practice (Hoboken, N.J.), 2014-09, Vol.1 (3), p.154-160

2014

Volltextzugriff (PDF)

Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease

JAMA neurology, 2014-07, Vol.71 (7), p.884

2014

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease

The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

New treatments for levodopa-induced motor complications

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

Sleep habits, alertness, cortisol levels, and cardiac autonomic activity in short-distance bus drivers: differences between morning and afternoon shifts

Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database

State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease

Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases

Diagnosis and Management of Pain in Parkinson's Disease: A New Approach

Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease

Heart Rate Nonlinear Dynamics During Sudden Hypoxia at 8230 m Simulated Altitude

Gender-related differences in urinary 6-sulfatoxymelatonin levels in obese pubertal individuals

Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO Trial

Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France

Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life

Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia

Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort

Cardiac autonomic activity predicts dominance in verbal over spatial reasoning tasks: Results from a preliminary study

What Is In A Name?

Test–retest reliability of the Friedreich’s ataxia rating scale

Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinson’s Disease

Movement Disorders in Autosomal Dominant Cerebellar Ataxias: A Systematic Review

Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease

Suchergebnisse filtern